Loading the company…
Loading the company…
㈜프린테크엘피엠
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-10-11 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Gyeonggi, founded in 2011. Industry: Food & Consumer Goods. Revenue for 2025 was ₩40.2bn. It has 23 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2020-12-10 · latest registration 2021-08-10 · newest first
본 발명은 항균 및 항곰팡이 기능을 갖는 멜라민 시트, 그 제조방법 및 시공방법에 관한 것으로, 더욱 상세하게는 멜라민 수지 100중량부, 옥틸이소티아졸리논 0.1~5중량부 및 디클롤로옥틸이소티아졸리논 0.1~5중량부를 포함하는 함침액이 종이에 함침된 것임을 특징으로 한다. 본 발명에 의하면, 항균, 항곰팡이성은 물론, 내오염성 및 내지문성이 우수하다는 장점이 있다.
본 발명은 방염성 저압 멜라민 시트와 그 제조방법에 관한 것으로, 전처리된 요소수지 및 멜라민수지에 의해 백화현상이 없고, 투명성 및 방염성을 구비한 저압 멜라민 시트와 그 제조방법을 제공하는 것이다. 본 발명은 요소수지 및 멜라민수지에 각각 인산염계 방염제를 첨가 교반하여 요소수지 함침액 및 멜라민수지 코팅액을 형성하는 전처리단계; 상기 요소수지 함침액에 모양지 또는 크라프트지를 함침 및 건조시키는 함침단계; 상기 함침단계 후, 모양지 또는 클라프트지에 멜라민수지 코팅액을 도포하여 코팅 및 건조시키는 코팅단계;를 포함하되, 상기 요소수지 함침액은 요소수지 100 중량부에, 인산염계 방염제 10~30중량부, 글리콜계 유화제 1~3중량부를 첨가하여 55~70rpm 으로 교반 형성되고, 상기 멜라민수지 코팅액은 멜라민수지 100 중량부에, 인산염계 방염제 10~30중량부, 글리콜계 유화제 1~3중량부를 첨가하여 55~70rpm 으로 교반 형성되며, 상기 인산염계 방염제는 (5-Ethyl-2-methyl-1,3,2-dioxaphosphorinan-5-yl)methyl dimethyl phosphonate P-oxide 65~75wt%, Bis[(5-ethyl-2-methyl-1,3,2-dioxaphosphorinan-5-yl)methyl] methyl phosphonate P,P''-dioxide...(이하생략)
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 2 of 2 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 54.8 | 40.2 |
| Cost of sales | 50.1 | 38.5 |
| Gross profit (loss) | 4.7 | 1.7 |
| Selling, general and administrative expenses | 3.5 | 2.4 |
| Operating income (loss) | 1.2 | (0.7) |
| Non-operating income | 0.3 | 0.9 |
| Other gains | 0.1 | 0.1 |
| Finance income | 0.0 | 0.0 |
| Other | 0.2 | 0.8 |
| Non-operating expenses | 1.1 | 1.9 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 1.0 | 0.9 |
| Other | 0.1 | 0.9 |
| Profit (loss) before tax | 0.3 | (1.7) |
| Income tax expense | 0.0 | 0.0 |
| Net income (loss) | 0.3 | (1.7) |
Revenue ₩40.2bn, down 26.6% YoY.
Operating margin -1.8% (prior 2.1%).
Net income ₩-1.7bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06